Addex Therapeutics Statistics

Total Valuation

ADXN has a market cap or net worth of $12.78 million. The enterprise value is $8.90 million.

Market Cap	12.78M
Enterprise Value	8.90M

Important Dates

The next estimated earnings date is Tuesday, May 28, 2024, before market open.

Earnings Date	May 28, 2024
Ex-Dividend Date	n/a

Share Statistics

ADXN has 1.49 million shares outstanding.

Shares Outstanding	1.49M
Owned by Insiders (%)	n/a
Owned by Institutions (%)	3.41%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.52
Forward PS	n/a
PB Ratio	10.14
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	4.54
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.46, with a Debt / Equity ratio of 0.30.

Current Ratio	1.46
Quick Ratio	1.37
Debt / Equity	0.30
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-30.15

Financial Efficiency

Return on equity (ROE) is -276.20% and return on invested capital (ROIC) is -690.11%.

Return on Equity (ROE)	-276.20%
Return on Assets (ROA)	-156.00%
Return on Capital (ROIC)	-690.11%
Revenue Per Employee	$85,252
Profits Per Employee	-$546,389
Employee Count	23
Asset Turnover	0.24
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -44.37% in the last 52 weeks. The beta is 1.82, so ADXN's price volatility has been higher than the market average.

Beta (1Y)	1.82
52-Week Price Change	-44.37%
50-Day Moving Average	14.20
200-Day Moving Average	9.57
Relative Strength Index (RSI)	33.34
Average Volume (30 Days)	20,756

Short Selling Information

Short Interest	14,663
Short Previous Month	21,710
Short % of Shares Out	0.05%
Short % of Float	n/a
Short Ratio (days to cover)	0.33

Income Statement

In the last 12 months, ADXN had revenue of $1.96 million and -$12.57 million in losses. Loss per share was -$0.15.

Revenue	1.96M
Gross Profit	1.81M
Operating Income	-11.31M
Pretax Income	-11.61M
Net Income	-12.57M
EBITDA	-10.90M
EBIT	-11.24M
Loss Per Share	-$0.15

Full Income Statement

Balance Sheet

The company has $4.25 million in cash and $378,828 in debt, giving a net cash position of $3.87 million or $2.60 per share.

Cash & Cash Equivalents	4.25M
Total Debt	378,828
Net Cash	3.87M
Net Cash Per Share	$2.60
Equity / Book Value	1.26M
Book Value Per Share	0.85
Working Capital	1.48M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$8.79 million and capital expenditures -$7,527, giving a free cash flow of -$8.80 million.

Operating Cash Flow	-8.79M
Capital Expenditures	-7,527
Free Cash Flow	-8.80M
FCF Per Share	-$14.10

Full Cash Flow Statement

Margins

Gross margin is 92.41%, with operating and profit margins of -576.87% and -640.91%.

Gross Margin	92.41%
Operating Margin	-576.87%
Pretax Margin	-592.29%
Profit Margin	-640.91%
EBITDA Margin	-556.11%
EBIT Margin	-573.28%
FCF Margin	-448.82%

Dividends & Yields

ADXN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-97.79%
Shareholder Yield	-97.79%
Earnings Yield	-98.35%
FCF Yield	-68.87%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on October 23, 2023. It was a reverse split with a ratio of 1:20.

Last Split Date	Oct 23, 2023
Split Type	Reverse
Split Ratio	1:20

Scores

ADXN has an Altman Z-Score of -113.24 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-113.24
Piotroski F-Score	4